Nina Aass

  • Professor II, Head of section Dr. med.
  • +47 23 02 76 29
 

Author network for Nina Aass by COREMINE medical


Publications 2018

Grotmol KS, Lie HC, Loge JH, Aass N, Haugen DF, Stone PC, Kaasa S, Hjermstad MJ (2018)
Patients with advanced cancer and depression report a significantly higher symptom burden than non-depressed patients
Palliat Support Care, 1-7 (in press)
DOI 10.1017/S1478951517001183, PubMed 29317008

Grønberg BH, Sjøblom B, Wentzel-Larsen T, Baracos VE, Hjermstad MJ, Aass N, Bremnes RM, Fløtten Ø, Bye A, Jordhøy M (2018)
A comparison of CT based measures of skeletal muscle mass and density from the Th4 and L3 levels in patients with advanced non-small-cell lung cancer
Eur J Clin Nutr (in press)
DOI 10.1038/s41430-018-0325-5, PubMed 30254241

Habberstad R, Frøseth TCS, Aass N, Abramova T, Baas T, Mørkeset ST, Caraceni A, Laird B, Boland JW, Rossi R, Garcia-Alonso E, Stensheim H, Loge JH, Hjermstad MJ, Bjerkeset E, Bye A, Lund JÅ, Solheim TS, Vagnildhaug OM, Brunelli C, Damås JK, Mollnes TE, Kaasa S, Klepstad P (2018)
The Palliative Radiotherapy and Inflammation Study (PRAIS) - protocol for a longitudinal observational multicenter study on patients with cancer induced bone pain
BMC Palliat Care, 17 (1), 110
DOI 10.1186/s12904-018-0362-9, PubMed 30266081

Jacobsen EL, Bye A, Aass N, Fosså SD, Grotmol KS, Kaasa S, Loge JH, Moum T, Hjermstad MJ (2018)
Correction to: Norwegian reference values for the Short-Form Health Survey 36: development over time
Qual Life Res, 27 (5), 1213-1215
DOI 10.1007/s11136-017-1708-0, PubMed 29168123

Publications 2017

Bye A, Sjøblom B, Wentzel-Larsen T, Grønberg BH, Baracos VE, Hjermstad MJ, Aass N, Bremnes RM, Fløtten Ø, Jordhøy M (2017)
Muscle mass and association to quality of life in non-small cell lung cancer patients
J Cachexia Sarcopenia Muscle, 8 (5), 759-767
DOI 10.1002/jcsm.12206, PubMed 28493418

Grotmol KS, Lie HC, Hjermstad MJ, Aass N, Currow D, Kaasa S, Moum TÅ, Pigni A, Loge JH, European Palliative Care Research Collaborative (EPCRC) (2017)
Depression-A Major Contributor to Poor Quality of Life in Patients With Advanced Cancer
J Pain Symptom Manage, 54 (6), 889-897
DOI 10.1016/j.jpainsymman.2017.04.010, PubMed 28803091

Jacobsen EL, Bye A, Aass N, Fosså SD, Grotmol KS, Kaasa S, Loge JH, Moum T, Hjermstad MJ (2017)
Norwegian reference values for the Short-Form Health Survey 36: development over time
Qual Life Res, 27 (5), 1201-1212
DOI 10.1007/s11136-017-1684-4, PubMed 28808829

Paulsen Ø, Laird B, Aass N, Lea T, Fayers P, Kaasa S, Klepstad P (2017)
The relationship between pro-inflammatory cytokines and pain, appetite and fatigue in patients with advanced cancer
PLoS One, 12 (5), e0177620
DOI 10.1371/journal.pone.0177620, PubMed 28542626

Publications 2016

Brelin S, Fredheim OM, Loge JH, Skurtveit S, Johannesen TB, Aass N, Ottesen S, Hjermstad MJ (2016)
Opioids for outpatients with cancer in their last year of life: A nationwide pharmacoepidemiological study
J Opioid Manag, 12 (1), 25-36
DOI 10.5055/jom.2016.0309, PubMed 26908301

Fredheim OM, Brelin S, Hjermstad MJ, Loge JH, Aass N, Johannesen TB, Skurtveit S (2016)
Prescriptions of analgesics during complete disease trajectories in patients who are diagnosed with and die from cancer within the five-year period 2005-2009
Eur J Pain, 21 (3), 530-540
DOI 10.1002/ejp.956, PubMed 27739657

Hjermstad MJ, Kaasa S, Caraceni A, Loge JH, Pedersen T, Haugen DF, Aass N, European Palliative Care Research Collaborative (EPCRC) (2016)
Characteristics of breakthrough cancer pain and its influence on quality of life in an international cohort of patients with cancer
BMJ Support Palliat Care, 6 (3), 344-52
DOI 10.1136/bmjspcare-2015-000887, PubMed 27342412

Hjermstad MJ, Aass N, Aielli F, Bennett M, Brunelli C, Caraceni A, Cavanna L, Fassbender K, Feio M, Haugen DF, Jakobsen G, Laird B, Løhre ET, Martinez M, Nabal M, Noguera-Tejedor A, Pardon K, Pigni A, Piva L, Porta-Sales J, Rizzi F, Rondini E, Sjøgren P, Strasser F, Turriziani A et al. (2016)
Characteristics of the case mix, organisation and delivery in cancer palliative care: a challenge for good-quality research
BMJ Support Palliat Care, 8 (4), 456-467
DOI 10.1136/bmjspcare-2015-000997, PubMed 27246166

Sjøblom B, Benth JŠ, Grønberg BH, Baracos VE, Sawyer MB, Fløtten Ø, Hjermstad MJ, Aass N, Jordhøy M (2016)
Drug Dose Per Kilogram Lean Body Mass Predicts Hematologic Toxicity From Carboplatin-Doublet Chemotherapy in Advanced Non-Small-Cell Lung Cancer
Clin Lung Cancer, 18 (2), e129-e136
DOI 10.1016/j.cllc.2016.09.008, PubMed 27825639

Sjøblom B, Grønberg BH, Wentzel-Larsen T, Baracos VE, Hjermstad MJ, Aass N, Bremnes RM, Fløtten Ø, Bye A, Jordhøy M (2016)
Skeletal muscle radiodensity is prognostic for survival in patients with advanced non-small cell lung cancer
Clin Nutr, 35 (6), 1386-1393
DOI 10.1016/j.clnu.2016.03.010, PubMed 27102408

Publications 2015

Paulsen Ø, Aass N, Klepstad P, Kaasa S (2015)
Reply to a. Molfino et Al
J Clin Oncol, 33 (13), 1513
DOI 10.1200/JCO.2014.60.6475, PubMed 25753433

Sjøblom B, Grønberg BH, Benth JŠ, Baracos VE, Fløtten Ø, Hjermstad MJ, Aass N, Jordhøy M (2015)
Low muscle mass is associated with chemotherapy-induced haematological toxicity in advanced non-small cell lung cancer
Lung Cancer, 90 (1), 85-91
DOI 10.1016/j.lungcan.2015.07.001, PubMed 26198373

Publications 2014

Paulsen O, Klepstad P, Rosland JH, Aass N, Albert E, Fayers P, Kaasa S (2014)
Efficacy of methylprednisolone on pain, fatigue, and appetite loss in patients with advanced cancer using opioids: a randomized, placebo-controlled, double-blind trial
J Clin Oncol, 32 (29), 3221-8
DOI 10.1200/JCO.2013.54.3926, PubMed 25002731

Publications 2013

Hjermstad MJ, Kolflaath J, Løkken AO, Hanssen SB, Normann AP, Aass N (2013)
Are emergency admissions in palliative cancer care always necessary? Results from a descriptive study
BMJ Open, 3 (5)
DOI 10.1136/bmjopen-2012-002515, PubMed 23793662

Nekolaichuk CL, Fainsinger RL, Aass N, Hjermstad MJ, Knudsen AK, Klepstad P, Currow DC, Kaasa S, European Palliative Care Research Collaborative (EPCRC) (2013)
The Edmonton Classification System for Cancer Pain: comparison of pain classification features and pain intensity across diverse palliative care settings in eight countries
J Palliat Med, 16 (5), 516-23
DOI 10.1089/jpm.2012.0390, PubMed 23614710

Publications 2012

Bergh I, Aass N, Haugen DF, Kaasa S, Hjermstad MJ (2012)
Symptom assessment in palliative medicine
Tidsskr Nor Laegeforen, 132 (1), 18-9
DOI 10.4045/tidsskr.11.1083, PubMed 22240824

Brelin S, Loge JH, Skurtveit S, Johannesen TB, Aass N, Ottesen S, Hjermstad MJ (2012)
Antidepressants to cancer patients during the last year of life--a population-based study
Psychooncology, 22 (3), 506-14
DOI 10.1002/pon.3059, PubMed 22392773

de Wit R, Skoneczna I, Daugaard G, De Santis M, Garin A, Aass N, Witjes AJ, Albers P, White JD, Germa-Lluch JR, Marreaud S, Collette L (2012)
Randomized phase III study comparing paclitaxel-bleomycin, etoposide, and cisplatin (BEP) to standard BEP in intermediate-prognosis germ-cell cancer: intergroup study EORTC 30983
J Clin Oncol, 30 (8), 792-9
DOI 10.1200/JCO.2011.37.0171, PubMed 22271474

Knudsen AK, Brunelli C, Klepstad P, Aass N, Apolone G, Corli O, Montanari M, Caraceni A, Kaasa S (2012)
Which domains should be included in a cancer pain classification system? Analyses of longitudinal data
Pain, 153 (3), 696-703
DOI 10.1016/j.pain.2011.12.005, PubMed 22264677

Knudsen AK, Klepstad P, Caraceni A, Kaasa S, Brunelli C, Aass N, Apolone G, Corli O, Montanari M (2012)
Cancer pain undertreatment and prognostic factors Response
Pain, 153 (8), 1771-1772

Knudsen AK, Aass N, Heitzer E, Klepstad P, Hjermstad MJ, Schippinger W, Brenne E, Kaasa S, Wasteson E, European Palliative Care Research Collaborative (EPCRC) (2012)
Interviews with patients with advanced cancer--another step towards an international cancer pain classification system
Support Care Cancer, 20 (10), 2491-500
DOI 10.1007/s00520-011-1361-z, PubMed 22252546

Paulsen Ø, Aass N, Kaasa S, Dale O (2012)
Do corticosteroids provide analgesic effects in cancer patients? A systematic literature review
J Pain Symptom Manage, 46 (1), 96-105
DOI 10.1016/j.jpainsymman.2012.06.019, PubMed 23149084

Rayment C, Hjermstad MJ, Aass N, Kaasa S, Caraceni A, Strasser F, Heitzer E, Fainsinger R, Bennett MI, European Palliative Care Research Collaborative (EPCRC) (2012)
Neuropathic cancer pain: prevalence, severity, analgesics and impact from the European Palliative Care Research Collaborative-Computerised Symptom Assessment study
Palliat Med, 27 (8), 714-21
DOI 10.1177/0269216312464408, PubMed 23175513

Publications 2011

Bennett MI, Rayment C, Hjermstad M, Aass N, Caraceni A, Kaasa S (2011)
Prevalence and aetiology of neuropathic pain in cancer patients: a systematic review
Pain, 153 (2), 359-65
DOI 10.1016/j.pain.2011.10.028, PubMed 22115921

Bergh I, Kvalem IL, Aass N, Hjermstad MJ (2011)
What does the answer mean? A qualitative study of how palliative cancer patients interpret and respond to the Edmonton Symptom Assessment System
Palliat Med, 25 (7), 716-24
DOI 10.1177/0269216310395985, PubMed 21248179

Hjermstad MJ, Fayers PM, Haugen DF, Caraceni A, Hanks GW, Loge JH, Fainsinger R, Aass N, Kaasa S, European Palliative Care Research Collaborative (EPCRC) (2011)
Studies comparing Numerical Rating Scales, Verbal Rating Scales, and Visual Analogue Scales for assessment of pain intensity in adults: a systematic literature review
J Pain Symptom Manage, 41 (6), 1073-93
DOI 10.1016/j.jpainsymman.2010.08.016, PubMed 21621130

Oliver RT, Mead GM, Rustin GJ, Joffe JK, Aass N, Coleman R, Gabe R, Pollock P, Stenning SP (2011)
Randomized trial of carboplatin versus radiotherapy for stage I seminoma: mature results on relapse and contralateral testis cancer rates in MRC TE19/EORTC 30982 study (ISRCTN27163214)
J Clin Oncol, 29 (8), 957-62
DOI 10.1200/JCO.2009.26.4655, PubMed 21282539

Publications 2010

Daugaard G, Skoneczna I, Aass N, De Wit R, De Santis M, Dumez H, Marreaud S, Collette L, Lluch JR, Bokemeyer C, Schmoll HJ (2010)
A randomized phase III study comparing standard dose BEP with sequential high-dose cisplatin, etoposide, and ifosfamide (VIP) plus stem-cell support in males with poor-prognosis germ-cell cancer. An intergroup study of EORTC, GTCSG, and Grupo Germinal (EORTC 30974)
Ann Oncol, 22 (5), 1054-61
DOI 10.1093/annonc/mdq575, PubMed 21059637

Haugnes HS, Wethal T, Aass N, Dahl O, Klepp O, Langberg CW, Wilsgaard T, Bremnes RM, Fosså SD (2010)
Cardiovascular risk factors and morbidity in long-term survivors of testicular cancer: a 20-year follow-up study
J Clin Oncol, 28 (30), 4649-57
DOI 10.1200/JCO.2010.29.9362, PubMed 20855830

Knudsen AK, Brunelli C, Kaasa S, Apolone G, Corli O, Montanari M, Fainsinger R, Aass N, Fayers P, Caraceni A, Klepstad P, European Palliative Care Research Collaborative, European Pharmacogenetic Study (2010)
Which variables are associated with pain intensity and treatment response in advanced cancer patients?--Implications for a future classification system for cancer pain
Eur J Pain, 15 (3), 320-7
DOI 10.1016/j.ejpain.2010.08.001, PubMed 20822941

Publications 2009

Haugnes HS, Aass N, Fosså SD, Dahl O, Brydøy M, Aasebø U, Wilsgaard T, Bremnes RM (2009)
Pulmonary function in long-term survivors of testicular cancer
J Clin Oncol, 27 (17), 2779-86
DOI 10.1200/JCO.2008.18.5181, PubMed 19414680

Knudsen AK, Aass N, Fainsinger R, Caraceni A, Klepstad P, Jordhøy M, Hjermstad MJ, Kaasa S (2009)
Classification of pain in cancer patients--a systematic literature review
Palliat Med, 23 (4), 295-308
DOI 10.1177/0269216309103125, PubMed 19286741

Publications 2008

Haugnes HS, Aass N, Fosså SD, Dahl O, Klepp O, Wist EA, Wilsgaard T, Bremnes RM (2008)
Predicted cardiovascular mortality and reported cardiovascular morbidity in testicular cancer survivors
J Cancer Surviv, 2 (3), 128-37
DOI 10.1007/s11764-008-0054-1, PubMed 18792787

Publications 2007

Holtan A, Aass N, Nordøy T, Haugen DF, Kaasa S, Mohr W, Kongsgaard UE (2007)
Prevalence of pain in hospitalised cancer patients in Norway: a national survey
Palliat Med, 21 (1), 7-13
DOI 10.1177/0269216306073127, PubMed 17169954

Rustin GJ, Mead GM, Stenning SP, Vasey PA, Aass N, Huddart RA, Sokal MP, Joffe JK, Harland SJ, Kirk SJ, National Cancer Research Institute Testis Cancer Clinical Studies Group (2007)
Randomized trial of two or five computed tomography scans in the surveillance of patients with stage I nonseminomatous germ cell tumors of the testis: Medical Research Council Trial TE08, ISRCTN56475197--the National Cancer Research Institute Testis Cancer Clinical Studies Group
J Clin Oncol, 25 (11), 1310-5
DOI 10.1200/JCO.2006.08.4889, PubMed 17416851

Publications 2006

Haugnes HS, Aass N, Fosså SD, Dahl O, Klepp O, Wist EA, Svartberg J, Wilsgaard T, Bremnes RM (2006)
Components of the metabolic syndrome in long-term survivors of testicular cancer
Ann Oncol, 18 (2), 241-8
DOI 10.1093/annonc/mdl372, PubMed 17060482

Jordhøy MS, Aass N, Svensen R, Ervik B, Mohr W (2006)
[Nausea, vomiting and constipation in palliative care]
Tidsskr Nor Laegeforen, 126 (5), 620-3
PubMed 16505875

Aass N, Bjordal K, Tveit KM, Nordøy T (2006)
[Tumour-modifying therapy]
Tidsskr Nor Laegeforen, 126 (5), 628-32
PubMed 16505877

Publications 2005

Oliver RT, Mason MD, Mead GM, von der Maase H, Rustin GJ, Joffe JK, de Wit R, Aass N, Graham JD, Coleman R, Kirk SJ, Stenning SP, MRC TE19 collaborators and the EORTC 30982 collaborators (2005)
Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial
Lancet, 366 (9482), 293-300
DOI 10.1016/S0140-6736(05)66984-X, PubMed 16039331

Sagstuen H, Aass N, Fosså SD, Dahl O, Klepp O, Wist EA, Wilsgaard T, Bremnes RM (2005)
Blood pressure and body mass index in long-term survivors of testicular cancer
J Clin Oncol, 23 (22), 4980-90
DOI 10.1200/JCO.2005.06.882, PubMed 16051950

Aass N, De Mulder PH, Mickisch GH, Mulders P, van Oosterom AT, van Poppel H, Fossa SD, de Prijck L, Sylvester RJ (2005)
Randomized phase II/III trial of interferon Alfa-2a with and without 13-cis-retinoic acid in patients with progressive metastatic renal cell Carcinoma: the European Organisation for Research and Treatment of Cancer Genito-Urinary Tract Cancer Group (EORTC 30951)
J Clin Oncol, 23 (18), 4172-8
DOI 10.1200/JCO.2005.07.114, PubMed 15961764

Publications 2004

Bjordal K, Aass N (2004)
[Palliative cytostatic treatment]
Tidsskr Nor Laegeforen, 124 (24), 3206-7
PubMed 15608767

Fosså SD, Aass N, Harvei S, Tretli S (2004)
Increased mortality rates in young and middle-aged patients with malignant germ cell tumours
Br J Cancer, 90 (3), 607-12
DOI 10.1038/sj.bjc.6601558, PubMed 14760372

Rapley EA, Hockley S, Warren W, Johnson L, Huddart R, Crockford G, Forman D, Leahy MG, Oliver DT, Tucker K, Friedlander M, Phillips KA, Hogg D, Jewett MA, Lohynska R, Daugaard G, Richard S, Heidenreich A, Geczi L, Bodrogi I, Olah E, Ormiston WJ, Daly PA, Looijenga LH, Guilford P et al. (2004)
Somatic mutations of KIT in familial testicular germ cell tumours
Br J Cancer, 90 (12), 2397-401
DOI 10.1038/sj.bjc.6601880, PubMed 15150569

Schmoll HJ, Souchon R, Krege S, Albers P, Beyer J, Kollmannsberger C, Fossa SD, Skakkebaek NE, de Wit R, Fizazi K, Droz JP, Pizzocaro G, Daugaard G, de Mulder PH, Horwich A, Oliver T, Huddart R, Rosti G, Paz Ares L, Pont O, Hartmann JT, Aass N, Algaba F, Bamberg M, Bodrogi I et al. (2004)
European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG)
Ann Oncol, 15 (9), 1377-99
DOI 10.1093/annonc/mdh301, PubMed 15319245

Stensvold E, Aass N, Gladhaug I, Stenwig AE, Claussen OP, Fosså SD (2004)
Erroneous diagnosis of pancreatic cancer after radiotherapy of testicular cancer
Eur J Surg Oncol, 30 (3), 352-5
DOI 10.1016/j.ejso.2003.09.006, PubMed 15028321

Aass N, Fosså SD (2004)
Pre- and post-treatment daily life function in patients with hormone resistant prostate carcinoma treated with radiotherapy for spinal cord compression
Radiother Oncol, 74 (3), 259-65
DOI 10.1016/j.radonc.2004.12.001, PubMed 15763306

Publications 2003

Christian JA, Huddart RA, Norman A, Mason M, Fossa S, Aass N, Nicholl EJ, Dearnaley DP, Horwich A (2003)
Intensive induction chemotherapy with CBOP/BEP in patients with poor prognosis germ cell tumors
J Clin Oncol, 21 (5), 871-7
DOI 10.1200/JCO.2003.05.155, PubMed 12610187

Fosså SD, Aass N, Heilo A, Daugaard G, E Skakkebaek N, Stenwig AE, Nesland JM, Looijenga LH, Oosterhuis JW (2003)
Testicular carcinoma in situ in patients with extragonadal germ-cell tumours: the clinical role of pretreatment biopsy
Ann Oncol, 14 (9), 1412-8
DOI 10.1093/annonc/mdg373, PubMed 12954581

Oldenburg J, Alfsen GC, Lien HH, Aass N, Waehre H, Fossa SD (2003)
Postchemotherapy retroperitoneal surgery remains necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses
J Clin Oncol, 21 (17), 3310-7
DOI 10.1200/JCO.2003.03.184, PubMed 12947067

Skotheim RI, Abeler VM, Nesland JM, Fosså SD, Holm R, Wagner U, Flørenes VA, Aass N, Kallioniemi OP, Lothe RA (2003)
Candidate genes for testicular cancer evaluated by in situ protein expression analyses on tissue microarrays
Neoplasia, 5 (5), 397-404
DOI 10.1016/S1476-5586(03)80042-8, PubMed 14670177

Publications 2002

Fosså SD, Aass N, Winderen M, Börmer OP, Olsen DR (2002)
Long-term renal function after treatment for malignant germ-cell tumours
Ann Oncol, 13 (2), 222-8
DOI 10.1093/annonc/mdf048, PubMed 11885998

Jacobsen KD, Fossa SD, Bjoro TP, Aass N, Heilo A, Stenwig AE (2002)
Gonadal function and fertility in patients with bilateral testicular germ cell malignancy
Eur. Urol., 42 (3), PII S0302-2838(02)00274-9-237

Jacobsen KD, Fosså SD, Bjøro TP, Aass N, Heilo A, Stenwig AE (2002)
Gonadal function and fertility in patients with bilateral testicular germ cell malignancy
Eur Urol, 42 (3), 229-38; discussion 237-8
PubMed 12234507

Ustun M, Heilo A, Fossa SD, Aass N, Berner A (2002)
Ultrasound-guided fine needle cytology of retroperitoneal masses in patients with malignant germ cell tumours: Diagnosis and therapeutic impact
Eur. Urol., 42 (3), PII S0302-2838(02)00310-X-228

Ustün M, Heilo A, Fosså S, Aass N, Berner A (2002)
Ultrasound-guided fine needle cytology of retroperitoneal masses in patients with malignant germ cell tumours: diagnosis and therapeutic impact
Eur Urol, 42 (3), 221-8; discussion 228
PubMed 12234506

Aass N, Fossa SD, Harvei S, Tretli S (2002)
Mortality rates in patients with malignant germ cell tumours (MGCT) with emphasis on second cancer and cardiovascular mortality
GERM CELL TUMOURS V, 209-210

Publications 2000

Cappelen T, Fosså SD, Stenwig AE, Aass N (2000)
False-negative biopsy for testicular intraepithelial neoplasia and high-risk features for testicular cancer
Acta Oncol, 39 (1), 105-9
PubMed 10752663

Fosså SD, Aass N, Tveter K, Dahl O (2000)
[Treatment of renal carcinoma with distant metastases]
Tidsskr Nor Laegeforen, 120 (19), 2274-8
PubMed 10997087

Skarstein J, Aass N, Fosså SD, Skovlund E, Dahl AA (2000)
Anxiety and depression in cancer patients: relation between the Hospital Anxiety and Depression Scale and the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire
J Psychosom Res, 49 (1), 27-34
DOI 10.1016/S0022-3999(00)00080-5, PubMed 11053601

Aass N, Lote K (2000)
Leakage of oncologists from clinical oncology in Norway
Lancet, 355 (9209), 1103
DOI 10.1016/S0140-6736(05)72228-5, PubMed 10744120

Publications 1999

Jacobsen KD, Ous S, Waehre H, Trasti H, Stenwig AE, Lien HH, Aass N, Fosså SD (1999)
Ejaculation in testicular cancer patients after post-chemotherapy retroperitoneal lymph node dissection
Br J Cancer, 80 (1-2), 249-55
DOI 10.1038/sj.bjc.6690347, PubMed 10390004

Publications 1998

Fosså SD, Aass N, Parö G (1998)
A phase II study of DaunoXome in advanced urothelial transitional cell carcinoma
Eur J Cancer, 34 (7), 1131-2
DOI 10.1016/S0959-8049(97)10156-3, PubMed 9849467

Aass N, Fosså SD, Dahl AA, Moe TJ (1998)
[Occurrence of anxiety and depression in cancer patients. An investigation at the Norwegian Radium Hospital]
Tidsskr Nor Laegeforen, 118 (5), 698-703
PubMed 9528365

Publications 1997

Duchesne GM, Stenning SP, Aass N, Mead GM, Fosså SD, Oliver RT, Horwich A, Read G, Roberts IT, Rustin G, Cullen MH, Kaye SB, Harland SJ, Cook PA (1997)
Radiotherapy after chemotherapy for metastatic seminoma--a diminishing role. MRC Testicular Tumour Working Party
Eur J Cancer, 33 (6), 829-35
DOI 10.1016/S0959-8049(97)00033-6, PubMed 9291801

Aass N, Fosså SD, Dahl AA, Moe TJ (1997)
Prevalence of anxiety and depression in cancer patients seen at the Norwegian Radium Hospital
Eur J Cancer, 33 (10), 1597-604
DOI 10.1016/S0959-8049(97)00054-3, PubMed 9389921

Aass N, Håtun DE, Thoresen M, Fosså SD (1997)
Prophylactic use of tropisetron or metoclopramide during adjuvant abdominal radiotherapy of seminoma stage I: a randomised, open trial in 23 patients
Radiother Oncol, 45 (2), 125-8
DOI 10.1016/S0167-8140(97)00099-6, PubMed 9424001

Publications 1996

Fossa SD, Aass N, Ous S, Waehre H, Ilner K, Hannisdal E (1996)
Survival after curative treatment of muscle-invasive bladder cancer
Acta Oncol, 35 Suppl 8, 59-65
DOI 10.3109/02841869609098521, PubMed 9073049

Lote K, Aass N (1996)
[Press coverage of medical issues]
Tidsskr Nor Laegeforen, 116 (2), 255-9
PubMed 8633337

Wiig JN, Aass N, Karlsen KO, Giercksky KE (1996)
[Colonic perforation during combined steroid and radiotherapy. Diagnosis and treatment]
Tidsskr Nor Laegeforen, 116 (6), 731-2
PubMed 8644074

Publications 1994

Fosså SD, Jacobsen AB, Aass N, Heilo A, Stenwig AE, Kummen O, Johannessen NB, Waaler G, Ogreid P, Borge L (1994)
How safe is surveillance in patients with histologically low-risk non-seminomatous testicular cancer in a geographically extended country with limited computerised tomographic resources?
Br J Cancer, 70 (6), 1156-60
DOI 10.1038/bjc.1994.464, PubMed 7981068

Fosså SD, Aass N, Opjordsmoen S (1994)
Assessment of quality of life in patients with prostate cancer
Semin Oncol, 21 (5), 657-61
PubMed 7524156

Opjordsmoen S, Waehre H, Aass N, Fossa SD (1994)
Sexuality in patients treated for penile cancer: patients' experience and doctors' judgement
Br J Urol, 73 (5), 554-60
DOI 10.1111/j.1464-410X.1994.tb07643.x, PubMed 8012779

Aass N, Fosså SD (1994)
Aims and results of palliative radiotherapy in urological cancer
Curr Opin Oncol, 6 (3), 308-12
PubMed 7521671

Publications 1993

Fosså SD, Waehre H, Aass N, Jacobsen AB, Olsen DR, Ous S (1993)
Bladder cancer definitive radiation therapy of muscle-invasive bladder cancer. A retrospective analysis of 317 patients
Cancer, 72 (10), 3036-43
DOI 10.1002/1097-0142(19931115)72:10<3036::AID-CNCR2820721028>3.0.CO;2-B, PubMed 8221571

Aass N, Grünfeld B, Kaalhus O, Fosså SD (1993)
Pre- and post-treatment sexual life in testicular cancer patients: a descriptive investigation
Br J Cancer, 67 (5), 1113-7
PubMed 8494708

Publications 1992

Heier MS, Aass N, Ous S, Fosså SD (1992)
Asymmetrical autonomic dysfunction of the feet after retroperitoneal surgery in patients with testicular cancer: 2 case reports
J Urol, 147 (2), 470-1
DOI 10.1016/S0022-5347(17)37278-6, PubMed 1732625

Aass N, Fosså SD, Høst H (1992)
Acute and subacute side effects due to infra-diaphragmatic radiotherapy for testicular cancer: a prospective study
Int J Radiat Oncol Biol Phys, 22 (5), 1057-64
DOI 10.1016/0360-3016(92)90808-U, PubMed 1555953

Publications 1991

Fosså SD, Aass N, Ous S, Waehre H (1991)
Long-term morbidity and quality of life in testicular cancer patients
Scand J Urol Nephrol Suppl, 138, 241-6
PubMed 1785014

Heier MS, Nilsen T, Graver V, Aass N, Fosså SD (1991)
Raynaud's phenomenon after combination chemotherapy of testicular cancer, measured by laser Doppler flowmetry. A pilot study
Br J Cancer, 63 (4), 550-2
DOI 10.1038/bjc.1991.129, PubMed 1850610

Kaasa S, Aass N, Mastekaasa A, Lund E, Fosså SD (1991)
Psychosocial well-being in testicular cancer patients
Eur J Cancer, 27 (9), 1091-5
DOI 10.1016/0277-5379(91)90299-S, PubMed 1683558

Lindegaard MW, Aass N, Bue ES, Theodorsen L, Fosså SD (1991)
Glomerular filtration rate, 131I-hippuran clearance and estimated creatinine clearance in cancer patients
Br J Cancer, 64 (2), 401-5
DOI 10.1038/bjc.1991.317, PubMed 1892774

Aass N, Fosså SD, Theodorsen L, Norman N (1991)
Prediction of long-term gonadal toxicity after standard treatment for testicular cancer
Eur J Cancer, 27 (9), 1087-91
DOI 10.1016/0277-5379(91)90298-R, PubMed 1720322

Aass N, Klepp O, Cavallin-Stahl E, Dahl O, Wicklund H, Unsgaard B, Baldetorp L, Ahlström S, Fosså SD (1991)
Prognostic factors in unselected patients with nonseminomatous metastatic testicular cancer: a multicenter experience
J Clin Oncol, 9 (5), 818-26
DOI 10.1200/JCO.1991.9.5.818, PubMed 1707957

Publications 1990

Fosså SD, Langmark F, Aass N, Andersen A, Lothe R, Børresen AL (1990)
Second non-germ cell malignancies after radiotherapy of testicular cancer with or without chemotherapy
Br J Cancer, 61 (4), 639-43
PubMed 2109999

Fosså SD, Ous S, Stenwig AE, Lien HH, Aass N, Kaalhus O (1990)
Distribution of retroperitoneal lymph node metastases in patients with non-seminomatous testicular cancer in clinical stage I
Eur Urol, 17 (2), 107-12
PubMed 2155789

Fosså SD, Saeter G, Aass N, Ous S, Stenwig AE, Blomlie V (1990)
Management of patients with poor-prognosis nonseminomatous germ cell cancer
Oncology, 47 (3), 234-40
DOI 10.1159/000226822, PubMed 1692984

Klepp O, Olsson AM, Henrikson H, Aass N, Dahl O, Stenwig AE, Persson BE, Cavallin-Ståhl E, Fosså SD, Wahlqvist L (1990)
Prognostic factors in clinical stage I nonseminomatous germ cell tumors of the testis: multivariate analysis of a prospective multicenter study. Swedish-Norwegian Testicular Cancer Group
J Clin Oncol, 8 (3), 509-18
DOI 10.1200/JCO.1990.8.3.509, PubMed 1689773

Aass N, Fosså SD, Ous S, Lien HH, Stenwig AE, Paus E, Kaalhus O (1990)
Is routine primary retroperitoneal lymph node dissection still justified in patients with low stage non-seminomatous testicular cancer?
Br J Urol, 65 (4), 385-90
DOI 10.1111/j.1464-410X.1990.tb14762.x, PubMed 2340372

Aass N, Fosså SD, Ous S, Stenwig AE, Lien HH, Paus E, Kaalhus O (1990)
Prognosis in patients with metastatic non-seminomatous testicular cancer
Radiother Oncol, 17 (4), 285-92
DOI 10.1016/0167-8140(90)90002-E, PubMed 1693003

Aass N, Fosså SD, Aas M, Lindegaard MW (1990)
Renal function related to different treatment modalities for malignant germ cell tumours
Br J Cancer, 62 (5), 842-6
DOI 10.1038/bjc.1990.391, PubMed 2173944

Aass N, Kaasa S, Lund E, Kaalhus O, Heier MS, Fosså SD (1990)
Long-term somatic side-effects and morbidity in testicular cancer patients
Br J Cancer, 61 (1), 151-5
DOI 10.1038/bjc.1990.31, PubMed 2297486

Publications 1989

Fosså SD, Aass N (1989)
Cisplatin-based chemotherapy does not eliminate the risk of a second testicular cancer
Br J Urol, 63 (5), 531-4
DOI 10.1111/j.1464-410X.1989.tb05951.x, PubMed 2543475

Fosså SD, Aass N, Kaalhus O (1989)
Long-term morbidity after infradiaphragmatic radiotherapy in young men with testicular cancer
Cancer, 64 (2), 404-8
DOI 10.1002/1097-0142(19890715)64:2<404::AID-CNCR2820640211>3.0.CO;2-7, PubMed 2736486

Fosså SD, Aass N, Kaalhus O (1989)
Radiotherapy for testicular seminoma stage I: treatment results and long-term post-irradiation morbidity in 365 patients
Int J Radiat Oncol Biol Phys, 16 (2), 383-8
DOI 10.1016/0360-3016(89)90334-9, PubMed 2921142

Fosså SD, Aass N, Molne K (1989)
Is routine pre-treatment cryopreservation of semen worthwhile in the management of patients with testicular cancer?
Br J Urol, 64 (5), 524-9
DOI 10.1111/j.1464-410X.1989.tb05292.x, PubMed 2611625

Fosså SD, Aass N, Molne K (1989)
Can we cure testicular cancer and retain fertility?
Prog Clin Biol Res, 303, 769-77
PubMed 2780672

Fosså SD, Aass N, Ous S (1989)
[Testicular cancer. A challenge to the health services taking care of young males]
Tidsskr Nor Laegeforen, 109 (3), 337-40
PubMed 2916218

Fosså SD, Aass N, Ous S, Høie J, Stenwig AE, Lien HH, Paus E, Kaalhus O (1989)
Histology of tumor residuals following chemotherapy in patients with advanced nonseminomatous testicular cancer
J Urol, 142 (5), 1239-42
DOI 10.1016/S0022-5347(17)39044-4, PubMed 2478726

Aass N, Fosså SD, Otto F, Ose T (1989)
Acute subjective morbidity after cisplatin-based combination chemotherapy in patients with testicular cancer: a prospective study
Radiother Oncol, 14 (1), 27-33
DOI 10.1016/0167-8140(89)90005-4, PubMed 2467328

Publications 1988

Fosså SD, Aass N, Kaalhus O (1988)
Testicular cancer in young Norwegians
J Surg Oncol, 39 (1), 43-63
DOI 10.1002/jso.2930390110, PubMed 3047500

Lien HH, Lindsköld L, Fosså SD, Aass N (1988)
Computed tomography and conventional radiography in intrathoracic metastases from non-seminomatous testicular tumor
Acta Radiol, 29 (5), 547-9
PubMed 3166874

Aass N, Fosså SD (1988)
Paternity in young patients with testicular cancer--expectations and experience
Prog Clin Biol Res, 269, 481-91
PubMed 2839852

Publications 1987

Fosså SD, Borge L, Aass N, Johannessen NB, Stenwig AE, Kaalhus O (1987)
The treatment of advanced metastatic seminoma: experience in 55 cases
J Clin Oncol, 5 (7), 1071-7
DOI 10.1200/JCO.1987.5.7.1071, PubMed 2439660

Publications 1986

Fosså SD, Aass N, Kaalhus O, Klepp O, Tveter K (1986)
Long-term survival and morbidity in patients with metastatic malignant germ cell tumors treated with cisplatin-based combination chemotherapy
Cancer, 58 (12), 2600-5
DOI 10.1002/1097-0142(19861215)58:12<2600::AID-CNCR2820581208>3.0.CO;2-D, PubMed 3022908

Publications 1980

Fodstad O, Aass N, Pihl A (1980)
An inverse relationship between the growth rate of human melanoma xenografts and their response to some cytostatic drugs
Br J Cancer, 41 (5), 829-31
DOI 10.1038/bjc.1980.149, PubMed 7426308

Fodstad O, Aass N, Pihl A (1980)
Assessment of tumour growth and of response to chemotherapy of human melanomas in athymic, nude mice
Br J Cancer Suppl, 4, 146-9
PubMed 6932918

Fodstad O, Aass N, Pihl A (1980)
Response to chemotherapy of human, malignant melanoma xenografts in athymic, nude mice
Int J Cancer, 25 (4), 453-8
DOI 10.1002/ijc.2910250405, PubMed 7372371

Page visits: 517